Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Identification of Potential Epilepsy Surgery Candidates : Article by

Quick Find
Authors & Editors
History
Medical Intractability
Consequences Of Uncontrolled Epilepsy
Clinical History
Surgically Remediable Syndromes
Diffuse Hemispheric Abnormalities Amenable To Focal Cortical Resection
Syndromes Excluded From Epilepsy Surgery
Diffuse Hemispheric Syndromes In Children
References




Patient Education
Click here for patient education.



Author: Erasmo A Passaro, MD, Director, Comprehensive Epilepsy Program/Clinical Neurophysiology Lab, Bayfront Medical Center

Erasmo A Passaro is a member of the following medical societies: American Academy of Neurology, American Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, and American Medical Association

Coauthor(s): Kirk W Jobe, MD, Consulting Staff, Comprehensive Epilepsy Program, Department of Neurosurgery, Bayfront Institute of Neurosciences

Editors: Joseph F Hulihan, MD, Vice President, Medical Affairs, Ortho-McNeil Janssen Scientific Affairs, LLC; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Jose E Cavazos, MD, PhD, Assistant Professor, Departments of Medicine (Neurology), Pharmacology, and Physiology, University of Texas Health Science Center at San Antonio; Selim R Benbadis, MD, Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and Neurosurgery, University of South Florida School of Medicine, Tampa General Hospital; Nicholas Y Lorenzo, MD, Chief Editor, eMedicine Neurology; Consulting Staff, Neurology Specialists and Consultants

Author and Editor Disclosure

Synonyms and related keywords: epilepsy surgery, epilepsy treatment, candidates for epilepsy surgery, epilepsy surgery centers, antiepileptic medications

Epilepsy surgery began in the late 19th century. Observations of ictal semiology by John Hughlings Jackson heralded the idea of localized cerebral function. He carefully noted ictal symptoms and correlated them with the anatomic location of cerebral lesions identified postmortem. In 1873, David Ferrier, through his cortical stimulation studies of monkeys, confirmed Jackson's clinical observation that cerebral functions were localized to specific brain regions.

The first successful surgery for an intracranial mass lesion localized solely by preoperative ictal symptoms was performed by William Macewen in Glasgow in 1879. On the basis of Jackson's work, Macewen correctly localized a frontal meningioma because the patient suffered from Jacksonian (ie, focal motor) seizures.

Although Macewen was the first to collect a large number of neurosurgical cases guided by ictal semiology, Sir Victor Horsley has been credited with initiating the modern era of epilepsy surgery. This credit was given to Horsley when he successfully localized and removed epileptogenic lesions in 3 patients with partial seizures at London's National Hospital in 1886 and published his report the same year in Brain. Horsley's first resection was performed on one of Jackson's patients, and both Jackson and Ferrier were present in the operating theater.

During the 20th century, the forefront of epilepsy surgery moved to Germany where Fedor Krause and Otfrid Foerster applied and standardized Horsley's techniques. Wilder Penfield, the 20th century's major figure in the field, received his epilepsy surgery training from Foerster. In 1934, Penfield started the Montreal Neurological Institute, where he and neurophysiologist Herbert Jasper established epilepsy surgery as a form of treatment for intractable epilepsy.

Penfield and colleagues found that a variety of signs and symptoms could be produced through electrical stimulation of certain brain regions. In the last 20-30 years, our knowledge regarding the localizing significance of ictal semiology has been enhanced through the use of video-EEG telemetry. Some of these epileptic syndromes, through advances in neuroimaging, are amenable to surgical treatment with an excellent prognosis for cure and minimal surgical morbidity.

In the last 10 years, epilepsy surgery has been recognized increasingly as a viable treatment for patients with medically refractory seizures. At the time of the first Palm Desert Conference in 1987, only 26 epilepsy surgery centers existed in the United States, performing approximately 500 therapeutic surgical procedures in 1985. According to the second Palm Desert Conference (1992), 67 epilepsy surgery programs were operational in the United States, performing approximately 1500 epilepsy surgeries in 1990.

At present, over 100 epilepsy centers exist in the United States. Unfortunately, it often takes 20 years before patients are referred for an epilepsy surgery evaluation. This delay is likely due to physician's perception of epilepsy surgery as a "last resort" procedure.
 
Most epilepsy centers define intractability as failure of at least 2 or 3 first-line antiepileptic medications. However, many physicians define medical intractability differently. They will often try numerous antiepileptic drug trials before referral for a presurgical evaluation is even considered, even though the prospect of becoming seizure free is only 5%.



Approximately 0.5-0.9% of the US population (ie, 2.5 million people) has been diagnosed with epilepsy. Half of these patients have partial seizures, and in 30% seizures are not controlled adequately with antiepileptic drugs (AEDs). A conservative estimate is that one half of patients with medically refractory seizures are potential candidates for epilepsy surgery. Another 10-15% of patients with epilepsy have severe secondary generalized seizure disorders that do not respond to AEDs. In the United States alone are 100,000 potential surgical candidates. According to Engel, an additional 5,000 potential surgical candidates are added to this pool each year.

Unfortunately, many primary care providers and even some neurologists believe that epilepsy surgery is a last-resort treatment. Many patients who could become seizure free with surgery undergo treatment with multiple medications over many years, suffering the adverse effects of recurrent seizures, the short- and long-term side effects of AEDs, and the psychosocial and occupational consequences of recurrent seizures.

Medical intractability is defined currently by many investigators as seizures that are not controlled after an adequate trial with 2 first-line AEDs. Some advocate at least 3 regimens, including 1 trial of 2-drug therapy. Determining intractability also requires an understanding of how the seizures affect the patients' quality of life (QOL) in terms of their psychological, interpersonal, and occupational functions. For example, even as few as 2-3 seizures a year may be disabling to an individual whose occupation requires transportation with a motor vehicle.

If 3 trials of monotherapy with first-line drugs are not successful, the chance that the patient will respond to a fourth drug as monotherapy or polytherapy is only 5%. A recent study by Kwan and Brodie revealed that only 47% of patients with untreated epilepsy became seizure free during treatment with the first AED, and 14% became seizure free with a second or third AED.

Similar findings were reported by Mattson et al from 2 Veterans Administration (VA) cooperative trials in patients untreated or inadequately treated with AEDs. They found that 60-70% of patients with generalized tonic-clonic seizures alone attained seizure freedom for at least 12 months. In patients with complex partial seizures, on the other hand, the prognosis was less favorable, with only 23-26% attaining seizure freedom for at least 12 months. These studies underscore the fact that patients with partial epilepsy who do not become seizure free after trials with 2 first-line AEDs are less likely to achieve seizure freedom with additional AED trials. In this regard, early identification of these patients with surgically remediable epilepsy is crucial, since the rate of seizure-free surgical outcome ranges from 70-80% in well-selected cases.

Furthermore, recent evidence from Berg and colleagues (2003) indicate that the prototype surgically remediable syndrome, mesial temporal lobe epilepsy, can have prolonged periods of remission before becoming intractable. For example, the Yale multicenter epilepsy surgery study found that, in the group with TLE, the average time to develop intractable epilepsy, defined as failure of 2 AEDs, was 9 years. Often, medial TLE begins in childhood but does not become refractory until adolescence or early adulthood. It appears that medial TLE can have a period of prolonged remission before becoming intractable.

A recent study of childhood onset epilepsy by Silanpaa and colleagues (2006) showed similar findings. Nineteen percent of children with epilepsy had intractable epilepsy without remission from the onset of their epilepsy, whereas 14% of children had an early or late remission (of 5 or more years) with subsequent intractability. In view of the finding that some cases of intractable epilepsy were well controlled early in their course, both physicians and patients alike may falsely believe that prolonged remission will once again occur, thus leading to prolonged AED trials even though this is not the case.

While in some patients, a delay occurs from onset to intractability, the time from medical intractability to surgery is also prolonged. In patients with childhood-onset and adolescent-onset epilepsy, the average time to referral is 15-16 years. In those with adult onset (age >20 y), the time to surgery is 4.5-7 years. In the UCLA series, the time from seizure onset to surgery has increased over the years from 12.5 years to 19 years. Another study reported similar findings where the average duration of epilepsy before referral was 18 years.

Furthermore, 39% of patients were self referred, and 36% of this group had been advised by their primary neurologist not to consider surgery. Therefore, both the early remission(s) of intractable epilepsy, which may lead to unnecessarily prolonged AED trials in hopes of once again attaining prolonged remission, and the misperceptions of the risks of epilepsy surgery by physicians and patients lead to prolonged delays to surgical referral.

With the approval of several newer AEDs and vagus nerve stimulation in the last few years, more treatment options are available. However, prolonged trials of AEDs in patients with well-defined, surgically remediable epilepsy (eg, hippocampal sclerosis or a well-defined structural lesion) offer diminishing chance for seizure freedom (5-10%) and delay surgical treatment that can reduce substantially or perhaps eliminate seizures.

A study by Semah and colleagues (1998) showed that the pathologic substrate of epilepsy indicated a poor long-term prognosis for remission. For example, patients with hippocampal sclerosis or cortical dysplasia had a poor prognosis, with the worse prognosis in patients with dual pathology defined as a structural lesion with concomitant hippocampal sclerosis. Other studies have shown similar findings. Therefore, recognition that patients with localization-related epilepsy with hippocampal sclerosis or a well-defined lesion have a universally poor prognosis with medical treatment but a good prognosis with surgical treatment is of utmost importance. These patients need to be identified early in life before the psychosocial consequences of prolonged disability prevent useful rehabilitation, even if the patient eventually undergoes epilepsy surgery, and becomes seizure free.



Patients with uncontrolled epilepsy often have low self-esteem, impaired social relationships, and reduced occupational function. Vickrey and colleagues compared QOL in patients with epilepsy to that of patients with hypertension, diabetes, heart disease, or depression. They found that patients who were seizure free after surgery scored better on QOL measures than the other patient groups. Patients who continue to have seizures after epilepsy surgery, on the other hand, scored worse in terms of emotional well-being and overall QOL.

A classic study by Sillanpaa and colleagues (1998) showed that adolescents with intractable epilepsy are less likely to finish high school, find employment, and get married. Evidence in the literature supports the idea that patients with more frequent seizures have worse QOL than those with fewer seizures. QOL decreases as seizure frequency increases to 10-12 seizure per year. However, once a frequency of one or more seizures per month is reached, QOL remains equally impaired with a seizure whether the seizure frequency is 2 or 20 seizures each month.

Mood disorders also occur with greater frequency in patients with epilepsy than in other patients with other medical conditions with a similar degree of disability. Approximately 20-30% of patients with epilepsy have a comorbid mood disorder. In patients with temporal lobe epilepsy, approximately 50% have concomitant mood disorders consisting of depression and anxiety. Recent studies have shown that patients with intractable epilepsy and comorbid depression who have similar seizure frequencies score worse on QOL measures than patients without depression.

Patients with intractable epilepsy also have loss of autonomy in that they are unable to drive and because family members often shield them from responsibility because of fear of injury. In fact, Gilliam et al reported that patients with intractable epilepsy report driving, independence, and employment as their most common concerns. Occupational status also is impaired in patients with intractable epilepsy. Sperling and colleagues reported that 71% of patients who were seizure free were employed, as compared to only 44% of patients with persistent seizures. Jacoby and colleagues (1996) also found that reduced employment levels were related to worsening seizure control. A European study involving 5000 patients in 15 countries showed that more than 50% of patients reported feeling a stigma associated with epilepsy. Public misperception also adversely affects the ability of patients with epilepsy to obtain employment.

Intractable epilepsy is also associated with reproductive endocrine disorders such as polycystic ovary syndrome, hypogonadotropic hypogonadism, and anovulatory cycles. Part of this increased risk is associated with certain AEDs such as valproate. Patients with epilepsy can also have reduced libido and reduced sexual arousal that may be related in part to the older enzyme-inducing AEDs (EIAEDS). Recent evidence indicated that these EIAEDS can produce sexual dysfunction in men by increasing the metabolism of testosterone and increasing the production of sex hormone binding globulin, thereby reducing free testosterone levels.

The risk for injury and mortality in patients with intractable epilepsy is greater than the general population. The overall mortality rate in persons with epilepsy is 2-3 times greater than the general population. This increased mortality risk is related to etiology of their epilepsy, degree of seizure control, and extent of neurologic handicap. The most common causes of mortality are sudden unexplained death and accidents.

Overall in persons with epilepsy, the risk for sudden unexplained death in epilepsy (SUDEP) is 24-fold greater than it is for the general population. However, in patients with medically intractable epilepsy, this risk is even greater, approaching 50-100 times the risk observed in the general population. In fact, SUDEP accounts for 7-17% of deaths in patients with epilepsy, and more than 50% of patients with intractable epilepsy.

In patients aged 15 years and older with uncontrolled epilepsy, the risk of dying is approximately 0.5% per year, and this risk accumulates over their lifetime. Patients whose seizures stop after surgery have mortality rates as low as the general population. Therefore, early surgical intervention in appropriate candidates can potentially reduce mortality.

They are also at increased risk for injury. One community-based study found that 35% of patients had sustained one or more injuries including head injury (24%), burn or scald (16%), dental injury (10%), and fracture (6%). The risk for injury is related to higher seizure frequency, seizure severity, and seizure type (generalized tonic-clonic and tonic).

Engel and Shewmon speculated that recurrent seizures themselves, the epileptogenic process, and/or reactive inhibitory mechanisms contribute to the progressive nature of epilepsy. They cite evidence for the progressive nature of epilepsy from phenomena such as kindling and secondary epileptogenesis in experimental animals. Whether these phenomena occur in humans is unknown. However, patients with refractory epilepsy clearly have impaired psychosocial and occupational functions that are less likely to improve the longer the seizures remain uncontrolled with surgery.

Epilepsy usually is viewed as an "ictal" disorder, and the interictal effects of chronic epilepsy have been largely ignored until recently. Patients with epilepsy also have interictal dysfunction, which includes material-specific memory deficits, mood disorders, neuropsychological dysfunction, and metabolic abnormalities in brain regions outside the epileptogenic region. For example, Krauss et al demonstrated that interictal spikes on depth electrode recording interfered with working memory in patients with temporal lobe epilepsy (TLE). This interictal dysfunction also significantly contributes to the morbidity of chronic epilepsy and may be potentially reversible. In this regard, Cendes and colleagues performed a recent study of patients with TLE; the study demonstrated that the interictal metabolic abnormalities on magnetic resonance spectroscopy that were observed in the contralateral temporal lobe prior to surgery partially returned to normal 3 months after epilepsy surgery.

Longitudinal studies of patients with chronic temporal lobe epilepsy have shown progressive hippocampal atrophy over time by volumetric MRI studies that correlates with duration of epilepsy and the number of generalized tonic-clonic seizures. Functional imaging data from PET show a relationship between epilepsy duration and the degree of hypometabolism in the temporal lobe.

The progressive nature of epilepsy is best exemplified by children with catastrophic epilepsy due to diffuse hemispheric disturbances. These patients develop normally until refractory infantile spasms develop. These seizures occur several times each day and are associated with developmental decline with loss of motor and language functions. The epileptogenic discharges from the abnormal hemisphere interfere with the normal development of the contralateral nonepileptogenic hemisphere. This decline becomes irreversible when the seizures persist beyond the critical period for development of certain skills, such as language. Invariably, these patients develop mental retardation and require chronic institutional care. Early identification of children who are candidates for functional hemispherectomy or multilobar resection is crucial, since cessation of seizures results in developmental improvement such that these patients can develop normally and can eventually lead relatively normal lives.

Intractable epilepsy has an enormous impact on various components of an individual's life including social, psychiatric, occupational, cognitive, and sexual functioning. It also increases their risk for injury and mortality. Intractable epilepsy may also be associated with progressive cognitive and structural/functional brain changes that can be reversible if identified and treated early. Epilepsy typically affects individuals before or during the most productive years of their life. Furthermore, the annual estimated cost of epilepsy in the US is $12.5 billion with most of the cost attributable to patients with intractable epilepsy. Therefore, it is imperative that patients with intractable epilepsy be referred for an epilepsy surgery evaluation with the goal of eliminating or reducing seizures, AED side effects, and restoring psychosocial function and QOL.



In the authors' experience, some patients report only simple partial seizures. However, upon further questioning of the patient and family, the occurrence of amnestic episodes of unresponsiveness or loss of time for which the patient is unable to account becomes apparent, suggesting unrecognized complex partial seizures. Some patients, particularly those who live or sleep alone, may have episodes of trauma to the lateral aspect of their tongue or may have urine incontinence upon awakening, indicating unrecognized secondarily generalized tonic-clonic seizures. Patients are usually unaware of seizures, unless environmental cues are present. In a study of patients admitted to an epilepsy-monitoring unit, Blum et al found that only 26% of patients always identified their seizures. Patients with right-sided temporal lobe seizures were aware of 50% of their seizures, and patients with left-sided temporal lobe seizures were aware of only 10% of their seizures.

Thus, obtaining a careful history from both the patient and the family members is essential. Determining how the seizures affect the patient's QOL is important. Family members can provide information about possible unrecognized seizures. With regard to assessing the impact of seizures on QOL, a useful question to ask the patient is "How would your life change if you no longer had seizures?"

During the interview, ask the patient about auras, since these have great value in localization. The importance of historical information has been recognized since Jackson used ictal characteristics to localize a patient's seizure. In a study by Palmini and Gloor, auras were found to be highly localizing. For example, an elementary visual aura suggests onset in the occipital lobe, a complex visual hallucination involving faces suggests onset near the fusiform or the inferior temporal gyrus, and an auditory aura is often associated with seizure onset in or near the superior temporal gyrus. While auras may represent spread from adjacent epileptogenic silent cortical regions to nonepileptogenic symptomatic regions, in many cases the aura can direct imaging with high-resolution MRI to identify a subtle cortical malformation.

Similarly, postictal deficits may provide lateralizing as well as localizing information. For example, postictal hemiparesis suggests onset near primary motor cortex, and a postictal language deficit suggests dominant hemisphere lateralization.



Temporal lobe epilepsy

The syndrome of medial TLE, which is associated with hippocampal sclerosis, is an example of a surgically remediable syndrome. Approximately 40-67% of these patients have a history of a complicated febrile convulsion (a febrile seizure lasting >30 min). These patients typically present with seizures in late childhood, at which time seizures are well controlled with AEDs. As the child enters adolescence and early adulthood, the seizures recur and become refractory to multiple medication trials.

Characteristic features of the syndrome

Many patients with TLE experience auras, which are simple partial seizures that precede most or all of their complex partial seizures and which often occur in isolation. These auras consist of autonomic phenomena, such as epigastric rising/nausea; olfactory auras, such as a strange taste or odor; or psychic auras, such as fear, déją vu/jamais vu, depersonalization, or derealization. Secondarily generalized tonic-clonic seizures, when present, are infrequent and easily controlled with AEDs.

These patients are hypothesized to have isolated auras and few generalized seizures because the hippocampus has few connections with the contralateral hippocampus, making seizure propagation slow. Their complex partial seizure consists of behavioral arrest; wide-eyed stare with pupillary dilation; and oral or alimentary automatisms, such as repetitive chewing and lip smacking. Since the hippocampus is involved bilaterally during the complex partial seizure, patients are amnestic for events that occur during the seizure.

Certain clinical features of temporal lobe seizures have lateralizing value. For example, ictal speech usually is associated with nondominant temporal lobe seizure onset. Dystonic limb posturing, when present, is contralateral to the side of temporal lobe seizure onset. This dystonic posturing usually involves flexion of the arm at the elbow with internal or external rotation of the forearm, flexion at the wrist, and extension of the fingers. Some patients may have ipsilateral head turning and contralateral dystonic posturing. Postictal nose wiping with one hand is defined as wiping of the nose twice in the postictal period. Geyer and colleagues demonstrated that the nose-wiping hand is usually ipsilateral to the temporal lobe of onset. Postictal dysnomia lasting for greater than 2 minutes suggests onset in the dominant temporal lobe. Other lateralizing signs in TLE include post-ictal thirst, peri-ictal urinary urge, and ictal spitting, which lateralize to the nondominant hemisphere.

Early clonic or tonic activity, or an aura suggesting extratemporal onset (ie, unilateral somatosensory aura, visual aura), places the diagnosis of medial TLE in doubt, since extratemporal foci may propagate to the medial temporal lobe and produce seizure semiology that is indistinguishable from medial temporal lobe onset seizures. Common extratemporal to medial temporal propagation pathways as described by Ajmone-Marsan and Ralston include (1) the cingulate gyrus to the medial temporal lobe through the cingulum, (2) the orbitofrontal cortex through the uncinate fasciculus, (3) the parietal lobe through the middle longitudinal fasciculus, and (4) the occipital lobe through the inferior longitudinal fasciculus.

The interictal EEG typically shows anterior to mid-temporal epileptiform discharges, which are usually unilateral but may be bilaterally independent in approximately 20-33% of cases. However, bilaterally independent, medial temporal interictal spikes do not necessarily indicate the presence of bilateral epileptogenic regions capable of generating spontaneous seizures. In fact, many patients with bilaterally independent temporal lobe interictal epileptiform abnormalities have their habitual seizure onsets in a single temporal lobe. In fact, patients with bilaterally independent temporal lobe seizure onsets and a lateralized MRI or PET and WADA testing can also be good surgical candidates.

High-resolution MRI using a T1-weighted, spoiled-gradient recall sequence with contiguous slices perpendicular to the long axis of the temporal lobe is most sensitive in detecting unilateral hippocampal atrophy in approximately 85% of patients. Hippocampal atrophy on MRI correlates with the presence of hippocampal sclerosis. Other MRI findings include increased signal in the hippocampus on conventional spin echo T2-weighted imaging. Clifford Jack and the Mayo Clinic group reported that MRI with fluid-attenuated inversion recovery (FLAIR) shows an even greater sensitivity for detecting signal changes within the abnormal sclerotic hippocampus than conventional spin echo T2-weighted imaging does. More recent data from Bernasconi and colleagues indicate that some patients may have entorhinal cortex atrophy in the absence of hippocampal atrophy.

Extratemporal lobe epilepsy

Extratemporal lobe epilepsy also may be treated effectively with epilepsy surgery, particularly when a clearly defined lesion is present on high-resolution MRI. In fact, surgical outcome improves from 20% seizure free in patients without a lesion to 70% seizure free in patients with a lesion. Extratemporal seizures may have variable seizure semiologies that represent seizure propagation patterns rather than the region of onset; however, these regions usually have selected pathways of propagation that may help to narrowly define the potential epileptogenic region.

Frontal lobe epilepsy

Seizures are typically brief, lasting seconds, with minimal postictal state. They usually occur in clusters, and they occur at night or predominantly in the morning. Unlike temporal lobe seizures, the semiology of frontal lobe seizures varies depending on the region of onset. For example, frontal lobe seizures propagate so rapidly that the clinical semiology may represent seizure propagation rather than the region of onset.

However, some clinical features of frontal lobe seizures may suggest a particular region of onset. For example, frontal lobe seizures characterized by staring for several seconds suggest medial frontal lobe onset. Seizures characterized by agitation with prominent motor activity and thrashing (ie, hypermotor seizure) suggest orbitofrontal onset. Seizures arising from the supplementary motor region in the medial frontal lobe anterior to the motor strip (area 6) are characterized by asymmetric tonic posturing of bilateral limbs, monotonous vocalization, and variable preservation of consciousness.

Forced head, eye, and body version suggests onset in the dorsolateral frontal lobe. With dorsolateral frontal lobe seizures, forced head and body version is usually contralateral to the hemisphere of onset. A recent study showed that nonforced head turning at ictal onset without a tonic component or hemi-facial clonic twitching was usually ipsilateral to the hemisphere of onset. Gyratory seizures are defined as a rotation around the body axis during the seizure at least 180 degrees. Gyratory seizures that begin with forced head version are usually contralateral, whereas gyratory seizures without forced head turning are usually ipsilateral to the hemisphere of onset.

Seizures arising from central regions consist of focal clonic, tonic, or tonic-clonic activity of the face, arm, and/or leg. Seizures arising from the frontal operculum consist of unilateral facial clonic twitching and profuse salivation, immediately followed by tonic posturing of all limbs.

With most frontal lobe epilepsies with the exception of orbitofrontal epilepsy, secondarily generalized tonic-clonic seizures are common since the frontal lobe neocortex has dense connections to other frontal and extrafrontal regions. In addition, the frontal lobe has dense callosal connections to the contralateral frontal lobe, allowing rapid contralateral propagation and subsequent secondary generalization. Auras are uncommon with frontal lobe seizures, and when present, they are usually nondescript.

Parietal lobe epilepsy

Seizures may be associated with a lateralized somatosensory phenomenon, vertigo, or a sense of motion. Anterior parietal lobe seizures usually mimic frontal lobe seizures because of spread to frontal lobe regions. Posterior parietal lobe seizures usually spread to the temporal lobe, producing temporal lobe semiology indistinguishable from seizures with primary origin from the temporal lobe.

Occipital lobe epilepsy

Seizures may be associated with a stereotyped visual aura consisting of unformed elementary visual phenomena, such as sparkles of light that some patients describe as "television static." Unlike migraine aura, which lasts several minutes, usually longer than 5 minutes, an epileptic visual aura is brief, lasting several seconds or as long as 1-2 minutes. In addition, an epileptic visual aura usually does not migrate across the visual field; however, the visual image may rotate in place. It may consist of colorful shapes that are present in the central visual field. Migraine aura also may consist of colorful shapes, but usually these are in the periphery and not in the central visual field.

Postictal blindness, when present, is a highly localizing finding that suggests occipital lobe onset. Although forced eye blinking during a seizure is nonspecific with regard to localization, if it occurs at seizure onset, it suggests occipital lobe seizure origin. When an occipital lobe simple partial seizure (aura) evolves into a complex partial seizure, it may be indistinguishable from a temporal lobe seizure or a frontal lobe seizure because of spread of the seizure discharge through the inferior longitudinal fasciculus (ie, temporal propagation) or the superior longitudinal fasciculus (ie, frontal propagation). Eye version in occipital lobe epilepsy can be either ipsilateral or contralateral to the epileptogenic region.

The pathologic substrate of extratemporal lobe seizures includes low-grade gliomas: developmental tumors such as gangliogliomas and dysembryoplastic neuroepithelial tumors, arteriovenous malformations (AVMs), cavernous angiomas, encephalomalacia, and malformations of cortical development.



Schizencephaly is defined as a cleft that is lined with gray matter. This cleft extends from the pial surface to the ventricle, usually is located in the central region, and often is associated with contralateral hemiparesis. It presents in 2 forms: a closed lip (type 1) and an open lip (type 2). If patients with schizencephaly have seizures with temporal lobe semiology, they may be candidates for an anterior temporal lobectomy. For example, if ictal EEG onset localizes to one temporal lobe, and the MRI shows unilateral hippocampal atrophy or the fluorodeoxyglucose positron emission tomography (FDG-PET) shows unilateral temporal hypometabolism, a unilateral anterior temporal lobectomy offers seizure freedom in 70% of cases.

Porencephaly is defined as a cyst that is contiguous to the lateral ventricle and most commonly is associated with a perinatal ischemic insult. Ho et al reported that patients with unilateral porencephaly, like those with schizencephaly, also might be excellent surgical candidates when they have seizures with temporal lobe semiology and noninvasive data that localize seizures to a single temporal lobe.

Patients with intractable epilepsy and vascular congenital hemiparesis can be surgical candidates for functional hemispherectomy if the seizures lateralize to the affected hemisphere or for anteromedial temporal resection if hippocampal atrophy and lateralized EEG findings are present. Similarly, patients with severe cerebral hemiatrophy and unilateral hippocampal sclerosis can also be good candidates for anteromedial temporal resections.

Earlier studies showed that patients with periventricular nodular heterotopias with seizure localization to the temporal lobe did poorly after temporal resection. More recent studies have shown that resection of the nodular heterotopias and sometimes adjacent neocortex can result in a favorable surgical outcome in many patients. These patients usually require invasive EEG monitoring with depth electrodes with or without concomitant subdural grid placement for localization of their epilepsy. In these cases, presurgical studies with magnetic source imaging and subtraction ictal SPECT are of importance in planning intracranial electrode placement.

Several studies from Miami Children's, the Mayo Clinic, the Montreal Neurologic Institute, and the Cleveland Clinic have shown that patients with tuberous sclerosis and localization-related epilepsy can also be good surgical candidates even when multiple cortical tubers are present and/or multifocal interictal epileptiform abnormalities are seen. With a thorough presurgical evaluation, a well-defined epileptogenic region can be identified that is amenable to surgical resection.



Patients who appear to have multiple seizure types arising from different brain regions are excluded from seizure surgery, unless one seizure type is the most frequent and disabling. Clinicians must be cautious because some patients have a clinical history that indicates multiple seizure types while video-EEG long-term monitoring of the patient reveals a single habitual seizure type.

Patients with bilateral hippocampal atrophy on MRI with poor memory and bilaterally independent seizure onsets usually have poor outcome. Those patients with bilateral hippocampal atrophy and unilateral ictal onsets usually are excluded from epilepsy surgery, unless the memory testing on WADA testing shows poor memory function ipsilateral to ictal onset and intact memory function on the contralateral side.

Patients with an idiopathic (ie, genetic) epilepsy, such as benign rolandic epilepsy or benign childhood epilepsy with occipital paroxysms, are not surgical candidates since their seizures remit by adolescence.

While a patient with low intelligence quotient (IQ) score is more likely to have more than one seizure localization and a less favorable outcome with surgery, these patients should not be excluded from presurgical evaluation. Many patients with a low IQ score have partial epilepsy that may allow a good seizure-free outcome with surgery. In addition, patients with disabling tonic/atonic seizures (ie, drop attacks) and low IQ score may benefit from corpus callosotomy as a palliative procedure or vagal nerve stimulation.

Adults with diffuse (multilobar) polymicrogyria or subcortical band heterotopia are poor surgical candidates even when localization-related epilepsy is found.



Children with intractable infantile spasms and diffuse hemispheric abnormalities, such as hemimegalencephaly, Sturge-Weber syndrome, porencephalic cyst, rasmussen encephalitis, or perinatal unilateral cerebral infarct, can be candidates for functional hemispherectomy or multilobar resection if the patient has a useless hand. These patients need to be identified early, particularly those with the dominant hemisphere affected, since language can shift to the opposite hemisphere if surgery is performed while the patient is younger than 6 years.

Some patients with infantile spasms and an EEG showing diffuse abnormalities (eg, hypsarrhythmia) may have a focal abnormality causing the seizures. Chugani and colleagues at UCLA demonstrated that FDG-PET is sensitive in identifying a focal region of hypometabolism in infants with medically intractable infantile spasms. More recently, Sankar reported that MRI performed in individuals older than 2 years, when myelination has occurred, identifies focal regions of cortical dysgenesis.

Summary

Over 200,000 people in the United States have intractable partial epilepsy, and a conservative estimate is that at least 50% of these patients are potential surgical candidates. These patients are at an increased risk for sudden death and personal injury. They are less likely to be employed than patients with well-controlled seizures. In addition, the epileptogenic process itself produces interictal dysfunction with adverse consequences on cognition and mood. After failure of 2 first-line AEDs, the chance for seizure freedom with additional therapeutic regimens may be as low as 5-10%.

Certain readily definable, surgically remediable syndromes are easily identified, have an excellent prognosis for seizure control, and have minimal surgical morbidity. Postoperatively, many patients with these syndromes have improved QOL and improved occupational outcome. In children with catastrophic epilepsy due to diffuse hemispheric syndromes, early surgical intervention stops seizures and reverses the cognitive decline so that these patients can develop normally, eventually leading relatively normal lives.



  • Agency for Healthcare Research and Quality. Management of Treatment Resistant Epilepsy. Agency for Healthcare Research and Quality. 2003;AHRQ Publication no. 03-0028:1-8. [Full Text].
  • Aghakhani Y, Kinay D, Gotman J. The role of periventricular nodular heterotopia in epileptogenesis. Brain. Mar 2005;128(Pt 3):641-51. [Medline].
  • Ajmone-Marsan C, Ralston BL, Charles C, eds. The Epileptic Seizure. Its Functional Morphology and Diagnostic Significance. Springfield IL: Thomas Publisher;1957.
  • Arts WF, Geerts AT, Brouwer OF. The early prognosis of epilepsy in childhood: the prediction of a poor outcome. The Dutch study of epilepsy in childhood. Epilepsia. Jun 1999;40(6):726-34. [Medline].
  • Austin JK, Dunn DW. Progressive behavioral changes in children with epilepsy. Prog Brain Res. 2002;135:419-27. [Medline].
  • Baker GA, Brooks J, Buck D. The stigma of epilepsy: a European perspective. Epilepsia. Jan 2000;41(1):98-104. [Medline].
  • Bauer J, Blumenthal S, Reuber M. Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy. Neurology. Jan 27 2004;62(2):243-6. [Medline].
  • Bauer J, Isojarvi JI, Herzog AG. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry. Aug 2002;73(2):121-5. [Medline].
  • Baumgartner C, Groppel G, Leutmezer F. Ictal urinary urge indicates seizure onset in the nondominant temporal lobe. Neurology. Aug 8 2000;55(3):432-4. [Medline].
  • Beghi E, Cornaggia C. Morbidity and accidents in patients with epilepsy: results of a European cohort study. Epilepsia. Sep 2002;43(9):1076-83. [Medline].
  • Begley CE, Beghi E, Beran RG. ILAE Commission on the Burden of Epilepsy, Subcommission on the Economic Burden of Epilepsy: Final report 1998-2001. Epilepsia. Jun 2002;43(6):668-73. [Medline].
  • Begley CE, Famulari M, Annegers JF. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data. Epilepsia. Mar 2000;41(3):342-51. [Medline].
  • Benbadis SR, Heriaud L, Tatum WO. Epilepsy surgery, delays and referral patterns-are all your epilepsy patients controlled?. Seizure. Apr 2003;12(3):167-70. [Medline].
  • Berg AT, Kelly MM. Defining intractability: comparisons among published definitions. Epilepsia. Feb 2006;47(2):431-6. [Medline].
  • Berg AT. Understanding the delay before epilepsy surgery: who develops intractable focal epilepsy and when?. CNS Spectr. Feb 2004;9(2):136-44. [Medline].
  • Berg AT, Langfitt J, Shinnar S. How long does it take for partial epilepsy to become intractable?. Neurology. Jan 28 2003;60(2):186-90. [Medline].
  • Bernasconi A, Martinez V, Rosa-Neto P. Surgical resection for intractable epilepsy in "double cortex" syndrome yields inadequate results. Epilepsia. Sep 2001;42(9):1124-9. [Medline].
  • Bernasconi N, Bernasconi A, Caramanos Z. Entorhinal cortex atrophy in epilepsy patients exhibiting normal hippocampal volumes. Neurology. May 22 2001;56(10):1335-9. [Medline].
  • Bernasconi N, Natsume J, Bernasconi A. Progression in temporal lobe epilepsy: differential atrophy in mesial temporal structures. Neurology. Jul 26 2005;65(2):223-8. [Medline].
  • Blum DE, Eskola J, Bortz JJ. Patient awareness of seizures. Neurology. Jul 1996;47(1):260-4. [Medline].
  • Briellmann RS, Berkovic SF, Syngeniotis A. Seizure-associated hippocampal volume loss: a longitudinal magnetic resonance study of temporal lobe epilepsy. Ann Neurol. May 2002;51(5):641-4. [Medline].
  • Bromfield EB, Altshuler L, Leiderman DB, et al. Published erratum appears in Arch Neurol 1992 Sep;49(9):976Cerebral metabolism and depression in patients with complex partial seizures. Arch Neurol. Jun 1992;49(6):617-23. [Medline].
  • Buck D, Baker GA, Jacoby A. Patients'' experiences of injury as a result of epilepsy. Epilepsia. Apr 1997;38(4):439-44. [Medline].
  • Camfield P, Camfield C, Gordon K. What types of epilepsy are preceded by febrile seizures? A population- based study of children. Dev Med Child Neurol. Oct 1994;36(10):887-92. [Medline].
  • Carreno M, Kotagal P, Perez Jimenez A. Intractable epilepsy in vascular congenital hemiparesis: clinical features and surgical options. Neurology. Jul 9 2002;59(1):129-31. [Medline].
  • Cendes F, Andermann F, Dubeau F. Normalization of neuronal metabolic dysfunction after surgery for temporal lobe epilepsy. Evidence from proton MR spectroscopic imaging. Neurology. Dec 1997;49(6):1525-33. [Medline].
  • Cendes F. Progressive hippocampal and extrahippocampal atrophy in drug resistant epilepsy. Curr Opin Neurol. Apr 2005;18(2):173-7. [Medline].
  • Chugani HT, Shields WD, Shewmon DA. Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol. Apr 1990;27(4):406-13. [Medline].
  • Dlugos DJ, Sammel MD, Strom BL. Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology. Dec 26 2001;57(12):2259-64. [Medline].
  • Dobesberger J, Walser G, Embacher N. Gyratory seizures revisited: a video-EEG study. Neurology. Jun 14 2005;64(11):1884-7. [Medline].
  • Elger CE, Helmstaedter C, Kurthen M. Chronic epilepsy and cognition. Lancet Neurol. Nov 2004;3(11):663-72. [Medline].
  • Engel J Jr, Henry TR, Swartz BE. Positron emission tomography in frontal lobe epilepsy. Adv Neurol. 1995;66:223-38; discussion 238-41. [Medline].
  • Engel J Jr. Historical Perspectives. Surgical Treatment of the Epilepsies. Philadelphia: Raven Press;1993:695-705.
  • Engel J Jr. Surgery for seizures. N Engl J Med. Mar 7 1996;334(10):647-52. [Medline].
  • Engel J Jr. Clinical evidence for the progressive nature of epilepsy. Epilepsy Res Suppl. 1996;12:9-20. [Medline].
  • Engel J Jr. Update on surgical treatment of the epilepsies. Summary of the Second International Palm Desert Conference on the Surgical Treatment of the Epilepsies (1992). Neurology. Aug 1993;43(8):1612-7. [Medline].
  • Fakhoury T, Abou-Khalil B. Association of ipsilateral head turning and dystonia in temporal lobe seizures. Epilepsia. Nov 1995;36(11):1065-70. [Medline].
  • Falconer MA, Serafetinides EA, Corsellis JA. Etiology and pathogenesis of temporal lobe epilepsy. Arch Neruol. 1964;10:233-48.
  • Ficker DM, So EL, Shen WK. Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology. Nov 1998;51(5):1270-1274. [Medline].
  • French JA, Williamson PD, Thadani VM. Characteristics of medial temporal lobe epilepsy: I. Results of history and physical examination. Ann Neurol. Dec 1993;34(6):774-80. [Medline].
  • Gaillard WD, Kopylev L, Weinstein S. Low incidence of abnormal (18)FDG-PET in children with new-onset partial epilepsy: a prospective study. Neurology. Mar 12 2002;58(5):717-22. [Medline].
  • Geyer JD, Payne TA, Faught E. Postictal nose-rubbing in the diagnosis, lateralization, and localization of seizures. Mar 10 1999;52(4):743-5. [Medline].
  • Gilliam F, Kuzniecky R, Faught E. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia. Feb 1997;38(2):233-6. [Medline].
  • Gilliam F. The impact of epilepsy on subjective health status. Curr Neurol Neurosci Rep. Jul 2003;3(4):357-62. [Medline].
  • Gloor P, Salanova V, Olivier A. The human dorsal hippocampal commissure. An anatomically identifiable and functional pathway. Brain. Oct 1993;116 ( Pt 5):1249-73. [Medline].
  • Guerreiro MM, Andermann F, Andermann E. Surgical treatment of epilepsy in tuberous sclerosis: strategies and results in 18 patients. Neurology. Nov 1998;51(5):1263-9. [Medline].
  • Harden CL. Sexuality in women with epilepsy. Epilepsy Behav. Dec 2005;7 Suppl 2:S2-6. [Medline].
  • Harvey AS, Hopkins IJ, Bowe JM. Frontal lobe epilepsy: clinical seizure characteristics and localization with ictal 99mTc-HMPAO SPECT. Neurology. Oct 1993;43(10):1966-80. [Medline].
  • Helmstaedter C. Effects of chronic epilepsy on declarative memory systems. Prog Brain Res. 2002;135:439-53. [Medline].
  • Helmstaedter C, Kurthen M, Lux S. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol. Oct 2003;54(4):425-32. [Medline].
  • Hermann BP, Wyler AR, Richey ET. Wisconsin Card Sorting Test performance in patients with complex partial seizures of temporal-lobe origin. J Clin Exp Neuropsychol. Aug 1988;10(4):467-76. [Medline].
  • Herzog AG, Drislane FW, Schomer DL. Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy. Neurology. Oct 11 2005;65(7):1016-20. [Medline].
  • Herzog AG, Harden CL, Liporace J. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol. Sep 2004;56(3):431-4. [Medline].
  • Ho SS, Berkovic SF, Newton MR. Parietal lobe epilepsy: clinical features and seizure localization by ictal SPECT. Neurology. Dec 1994;44(12):2277-84. [Medline].
  • Ho SS, Kuzniecky RI, Gilliam F. Congenital porencephaly and hippocampal sclerosis. Clinical features and epileptic spectrum. Neurology. Nov 1997;49(5):1382-8. [Medline].
  • Jack CR Jr, Rydberg CH, Krecke KN. Mesial temporal sclerosis: diagnosis with fluid-attenuated inversion-recovery versus spin-echo MR imaging. Radiology. May 1996;199(2):367-73. [Medline].
  • Jack CR Jr, Sharbrough FW, Cascino GD. Magnetic resonance image-based hippocampal volumetry: correlation with outcome after temporal lobectomy. Ann Neurol. Feb 1992;31(2):138-46. [Medline].
  • Jacoby A, Baker GA, Steen N. The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study. Epilepsia. Feb 1996;37(2):148-61. [Medline].
  • Jarrar RG, Buchhalter JR, Raffel C. Long-term outcome of epilepsy surgery in patients with tuberous sclerosis. Neurology. Feb 10 2004;62(3):479-81. [Medline].
  • Jokeit H, Seitz RJ, Markowitsch HJ. Prefrontal asymmetric interictal glucose hypometabolism and cognitive impairment in patients with temporal lobe epilepsy. Brain. Dec 1997;120 ( Pt 12):2283-94. [Medline].
  • Jokeit H, Ebner A. Effects of chronic epilepsy on intellectual functions. Prog Brain Res. 2002;135:455-63. [Medline].
  • Kanner AM, Palac S. Depression in Epilepsy: A Common but Often Unrecognized Comorbid Malady. Epilepsy Behav. Feb 2000;1(1):37-51. [Medline].
  • Kapur N, Prevett M. Unexpected amnesia: are there lessons to be learned from cases of amnesia following unilateral temporal lobe surgery?. Brain. Dec 2003;126(Pt 12):2573-85. [Medline].
  • Koh S, Jayakar P, Dunoyer C. Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome. Epilepsia. Sep 2000;41(9):1206-13. [Medline].
  • Kotagal P, Arunkumar GS. Lateral frontal lobe seizures. Epilepsia. 1998;39 Suppl 4:S62-8. [Medline].
  • Kotagal P, Luders H, Morris HH. Dystonic posturing in complex partial seizures of temporal lobe onset: a new lateralizing sign. Neurology. Feb 1989;39(2 Pt 1):196-201. [Medline].
  • Krauss GL, Summerfield M, Brandt J. Mesial temporal spikes interfere with working memory. Neurology. Oct 1997;49(4):975-80. [Medline].
  • Kuzniecky R, Gilliam F, Morawetz R. Occipital lobe developmental malformations and epilepsy: clinical spectrum, treatment, and outcome. Epilepsia. Feb 1997;38(2):175-81. [Medline].
  • Kuzniecky RI, Bilir E, Gilliam F. Multimodality MRI in mesial temporal sclerosis: relative sensitivity and specificity. Neurology. Sep 1997;49(3):774-8. [Medline].
  • Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. Feb 3 2000;342(5):314-9. [Medline].
  • Lachhwani DK, Pestana E, Gupta A. Identification of candidates for epilepsy surgery in patients with tuberous sclerosis. Neurology. May 10 2005;64(9):1651-4. [Medline].
  • Laff R, Mesad S, Devinsky O. Epileptic kinetopsia: ictal illusory motion perception. Neurology. Nov 11 2003;61(9):1262-4. [Medline].
  • Landy HJ, Ramsay RE, Ajmone-Marsan C. Temporal lobectomy for seizures associated with unilateral schizencephaly. Surg Neurol. Jun 1992;37(6):477-81. [Medline].
  • Li LM, Cendes F, Watson C. Surgical treatment of patients with single and dual pathology: relevance of lesion and of hippocampal atrophy to seizure outcome. Neurology. Feb 1997;48(2):437-44. [Medline].
  • Li LM, Cendes F, Andermann F. Surgical outcome in patients with epilepsy and dual pathology. Brain. May 1999;122 ( Pt 5):799-805. [Medline].
  • Lieb JP, Babb TL. Interhemispheric propagation time of human hippocampal seizures: II. Relationship to pathology and cell density. Epilepsia. May-Jun 1986;27(3):294-300. [Medline].
  • Lieb JP, Engel J Jr, Babb TL. Interhemispheric propagation time of human hippocampal seizures. I. Relationship to surgical outcome. Epilepsia. May-Jun 1986;27(3):286-93. [Medline].
  • Liu RS, Lemieux L, Bell GS. Progressive neocortical damage in epilepsy. Ann Neurol. Mar 2003;53(3):312-24. [Medline].
  • Martin RC, Sawrie SM, Knowlton RC. Bilateral hippocampal atrophy: consequences to verbal memory following temporal lobectomy. Neurology. Aug 28 2001;57(4):597-604. [Medline].
  • Mattson RH, Cramer JA, Collins JF. Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Department of Veterans Affairs Epilepsy Cooperative Studies No. 118 and No. 264 Group. Neurology. Jul 1996;47(1):68-76. [Medline].
  • McLachlan RS, Rose KJ, Derry PA. Health-related quality of life and seizure control in temporal lobe epilepsy. Ann Neurol. Apr 1997;41(4):482-9. [Medline].
  • Morris HH 3d, Dinner DS, Luders H. Supplementary motor seizures: clinical and electroencephalographic findings. Neurology. Jul 1988;38(7):1075-82. [Medline].
  • Neufeld MY, Vishne T, Chistik V. Life-long history of injuries related to seizures. Epilepsy Res. Apr 1999;34(2-3):123-7. [Medline].
  • Newton MR, Berkovic SF, Austin MC. Postictal switch in blood flow distribution and temporal lobe seizures. J Neurol Neurosurg Psychiatry. Oct 1992;55(10):891-4. [Medline].
  • Oyegbile TO, Dow C, Jones J. The nature and course of neuropsychological morbidity in chronic temporal lobe epilepsy. Neurology. May 25 2004;62(10):1736-42. [Medline].
  • Palmini A, Gloor P. The localizing value of auras in partial seizures: a prospective and retrospective study. Neurology. Apr 1992;42(4):801-8. [Medline].
  • Panayiotopoulos CP. Elementary visual hallucinations in migraine and epilepsy. J Neurol Neurosurg Psychiatry. Nov 1994;57(11):1371-4. [Medline].
  • Privitera M, Kohler C, Cahill W. Postictal language dysfunction in patients with right or bilateral hemispheric language localization. Epilepsia. Oct 1996;37(10):936-41. [Medline].
  • Racoosin JA, Feeney J, Burkhart G. Mortality in antiepileptic drug development programs. Neurology. Feb 27 2001;56(4):514-9. [Medline].
  • Reeves AL, So EL, Evans RW. Factors associated with work outcome after anterior temporal lobectomy for intractable epilepsy. Epilepsia. Jun 1997;38(6):689-95. [Medline].
  • Rheims S, Demarquay G, Isnard J. Ipsilateral head deviation in frontal lobe seizures. Epilepsia. Nov 2005;46(11):1750-3. [Medline].
  • Salmenpera T, Kalviainen R, Partanen K. Hippocampal and amygdaloid damage in partial epilepsy: a cross-sectional MRI study of 241 patients. Epilepsy Res. Jul 2001;46(1):69-82. [Medline].
  • Salmenpera T, Kononen M, Roberts N. Hippocampal damage in newly diagnosed focal epilepsy: a prospective MRI study. Neurology. Jan 11 2005;64(1):62-8. [Medline].
  • Sankar R, Curran JG, Kevill JW. Microscopic cortical dysplasia in infantile spasms: evolution of white matter abnormalities. Am J Neuroradiol. Jun-Jul 1995;16(6):1265-72. [Medline].
  • Schulz R, Luders HO, Tuxhorn I. Localization of epileptic auras induced on stimulation by subdural electrodes. Epilepsia. Dec 1997;38(12):1321-9. [Medline].
  • Semah F, Picot MC, Adam C. Is the underlying cause of epilepsy a major prognostic factor for recurrence?. Neurology. Nov 1998;51(5):1256-62. [Medline].
  • Shackleton DP, Kasteleijn-Nolst Trenite DG, de Craen AJ. Living with epilepsy: long-term prognosis and psychosocial outcomes. Neurology. Jul 8 2003;61(1):64-70. [Medline].
  • Sillanpaa M, Jalava M, Kaleva O. Long-term prognosis of seizures with onset in childhood. N Engl J Med. Jun 11 1998;338(24):1715-22. [Medline].
  • So N, Olivier A, Andermann F. Results of surgical treatment in patients with bitemporal epileptiform abnormalities. Ann Neurol. May 1989;25(5):432-9. [Medline].
  • So NK. Mesial frontal epilepsy. Epilepsia. 1998;39 Suppl 4:S49-61. [Medline].
  • Sperling MR, O''Connor MJ, Saykin AJ. Temporal lobectomy for refractory epilepsy. JAMA. Aug 14 1996;276(6):470-5. [Medline].
  • Sperling MR. The consequences of uncontrolled epilepsy. CNS Spectr. Feb 2004;9(2):98-101, 106-9. [Medline].
  • Sperling MR, Feldman H, Kinman J. Seizure control and mortality in epilepsy. Ann Neurol. Jul 1999;46(1):45-50. [Medline].
  • Sperling MR, O''Connor MJ, Saykin AJ. Temporal lobectomy for refractory epilepsy. JAMA. Aug 14 1996;276(6):470-5. [Medline].
  • Stephen LJ, Kwan P, Brodie MJ. Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment?. Epilepsia. Mar 2001;42(3):357-62. [Medline].
  • Sutula T, Cascino G, Cavazos J. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol. Sep 1989;26(3):321-30. [Medline].
  • Swarztrauber K. Barriers to the management of patients with surgically remediable intractable epilepsy. CNS Spectr. Feb 2004;9(2):146-52. [Medline].
  • Swarztrauber K, Dewar S, Engel J. Patient attitudes about treatments for intractable epilepsy. Epilepsy Behav. Feb 2003;4(1):19-25. [Medline].
  • Tassi L, Colombo N, Cossu M. Electroclinical, MRI and neuropathological study of 10 patients with nodular heterotopia, with surgical outcomes. Brain. Feb 2005;128(Pt 2):321-37. [Medline].
  • Theodore WH, Bhatia S, Hatta J. Hippocampal atrophy, epilepsy duration, and febrile seizures in patients with partial seizures. Neurology. Jan 1 1999;52(1):132-6. [Medline].
  • Theodore WH, Gaillard WD. Neuroimaging and the progression of epilepsy. Prog Brain Res. 2002;135:305-13. [Medline].
  • Trinka E, Walser G, Unterberger I. Peri-ictal water drinking lateralizes seizure onset to the nondominant temporal lobe. Neurology. Mar 11 2003;60(5):873-6. [Medline].
  • Vickrey BG, Hays RD, Rausch R. Quality of life of epilepsy surgery patients as compared with outpatients with hypertension, diabetes, heart disease, and/or depressive symptoms. Epilepsia. May-Jun 1994;35(3):597-607. [Medline].
  • Vinters HV, Armstrong DL, Babb TL. The neuropathology of human symptomatic epilepsy. In: Surgical Treatment of the Epilepsies. Philadelphia: Raven Press;1993:593-608.
  • Williamson PD, Thadani VM, Darcey TM. Occipital lobe epilepsy: clinical characteristics, seizure spread patterns, and results of surgery. Ann Neurol. Jan 1992;31(1):3-13. [Medline].
  • Williamson PD, Boon PA, Thadani VM. Parietal lobe epilepsy: diagnostic considerations and results of surgery. Ann Neurol. Feb 1992;31(2):193-201. [Medline].
  • Williamson PD, French JA, Thadani VM. Characteristics of medial temporal lobe epilepsy: II. Interictal and ictal scalp electroencephalography, neuropsychological testing, neuroimaging, surgical results, and pathology. Ann Neurol. Dec 1993;34(6):781-7. [Medline].
  • Williamson PD. Frontal lobe epilepsy. Some clinical characteristics. Adv Neurol. 1995;66:127-50; discussion 150-2. [Medline].

Identification of Potential Epilepsy Surgery Candidates excerpt

Article Last Updated: Apr 12, 2006